106.961 articles found

COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS

CHENARD Bertrand L., MENNITI Frank S..

· 1995-05-26

COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS

CHENARD Bertrand L., MENNITI Frank S..

· 1995-05-26

Therapeutic agent for Parkinson's disease

SUZUKI FUMIO, SHIMADA JUNICHI, KOIKE NOBUAKI, NAKAMURA JOJI, SHIOZAKI SHIZUO, ICHIKAWA SHUNJI, ISHII AKIO, NONAKA HIROMI.

· 1995-05-23

L-DOPA ethyl ester to treat Parkinson's disease

MILMAN ISAAC, VEINBERG ALEXANDER, ATLAS DAPHNE, MELAMED ELDAD.

· 1995-05-17

Clozapine therapeutic plunge in patient with Parkinson's disease.

Greene P.

Lancet · 1995-05-01

DOI: 10.1016/s0140-6736(95)91001-8PMID: 7723559

Drug-licensing anomalies and Parkinson's disease.

Brookes RW, Moore T.

Lancet · 1995-05-01

DOI: 10.1016/s0140-6736(95)91008-5PMID: 7723567

Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease.

Cutson TM, Laub KC, Schenkman M.

Phys Ther · 1995-05-01

DOI: 10.1093/ptj/75.5.363PMID: 7732080

Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder.

Pridmore S, Yeo PT, Pasha MI.

J Neurol Neurosurg Psychiatry · 1995-05-01

DOI: 10.1136/jnnp.58.5.641-aPMID: 7745424

Hemiballism in Parkinson's disease.

Obeso JA, Guridi J, Linazasoro G, Ramos E.

J Neurol Neurosurg Psychiatry · 1995-05-01

DOI: 10.1136/jnnp.58.5.645-bPMID: 7745426

Apolipoprotein E4 in Parkinson's disease.

Korczyn AD.

Neurology · 1995-05-01

DOI: 10.1212/wnl.45.5.1025-aPMID: 7746382

Hormones and Parkinson's disease.

Giladi N, Honigman S.

Neurology · 1995-05-01

DOI: 10.1212/wnl.45.5.1028-aPMID: 7746387

The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease.

Garcia PA, Aminoff MJ, Goodin DS.

Neurology · 1995-05-01

DOI: 10.1212/wnl.45.5.989PMID: 7746421